Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6651
Genworth Financial
GNW
$3.84B
| $1.08M | ﹤0.01% |
157,841
-1,127,820
| -88% | -$7.42M |
|
6652
CALL
Ligand Pharmaceuticals
LGND
$5.8B
| $1.08M | ﹤0.01% |
10,800
-15,300
| -59% | -$1.54M |
|
6653
PUT
Alamo Group
ALG
$1.96B
| $1.08M | ﹤0.01% |
6,000
+4,000
| +200% | +$713K |
|
6654
ProShares Short 20+ Year Treasury ETF
TBF
$108M
| $1.08M | ﹤0.01% |
48,781
+12,778
| +35% | +$289K |
|
|
TERN
6655
CALL
DELISTED
Terns Pharmaceuticals
TERN
| $1.08M | ﹤0.01% |
129,400
+65,500
| +103% | +$539K |
|
6656
LegalZoom.com
LZ
$957M
| $1.08M | ﹤0.01% |
+169,925
| New | +$1.11M |
|
6657
Invesco S&P 500 High Beta ETF
SPHB
$942M
| $1.08M | ﹤0.01% |
12,079
+3,114
| +35% | +$265K |
|
6658
PUT
TORM
TRMD
$3.11B
| $1.08M | ﹤0.01% |
31,500
-2,500
| -7% | -$91.7K |
|
6659
CALL
RUM Group Inc
RUM
$4.09B
| $1.08M | ﹤0.01% |
200,900
+19,500
| +11% | +$115K |
|
6660
CALL
Xometry
XMTR
$5.05B
| $1.08M | ﹤0.01% |
58,600
+19,300
| +49% | +$317K |
|
|
ACCD
6661
PUT
DELISTED
Accolade Inc
ACCD
| $1.08M | ﹤0.01% |
279,600
+6,900
| +3% | +$27K |
|
|
CHX
6662
PUT
DELISTED
ChampionX
CHX
| $1.08M | ﹤0.01% |
35,700
-11,100
| -24% | -$351K |
|
6663
PUT
BioCryst Pharmaceuticals
BCRX
$2.53B
| $1.08M | ﹤0.01% |
141,600
-70,500
| -33% | -$536K |
|
6664
ALPS O'Shares Global Internet Giants ETF
OGIG
$111M
| $1.08M | ﹤0.01% |
25,737
-17,306
| -40% | -$673K |
|
6665
VictoryShares Dividend Accelerator ETF
VSDA
$239M
| $1.08M | ﹤0.01% |
20,240
-16,131
| -44% | -$820K |
|
6666
PUT
United States Copper Index Fund
CPER
$743M
| $1.07M | ﹤0.01% |
37,900
-7,100
| -16% | -$189K |
|
6667
PUT
Viridian Therapeutics
VRDN
$2.65B
| $1.07M | ﹤0.01% |
47,200
+42,300
| +863% | +$692K |
|
|
GOLD
6668
PUT
Gold.com Inc
GOLD
$1.27B
| $1.07M | ﹤0.01% |
24,300
-6,000
| -20% | -$230K |
|
6669
Savers
SVV
$1.62B
| $1.07M | ﹤0.01% |
101,966
-24,006
| -19% | -$245K |
|
6670
Adaptive Biotechnologies
ADPT
$3.9B
| $1.07M | ﹤0.01% |
209,426
-192,696
| -48% | -$840K |
|
6671
CALL
Aehr Test Systems
AEHR
$4.45B
| $1.07M | ﹤0.01% |
83,300
-55,400
| -40% | -$801K |
|
6672
First Trust Dorsey Wright Momentum & Low Volatility ETF
DVOL
$74.2M
| $1.07M | ﹤0.01% |
32,221
+15,607
| +94% | +$495K |
|
|
SWTX
6673
PUT
DELISTED
SpringWorks Therapeutics
SWTX
| $1.07M | ﹤0.01% |
33,300
-6,600
| -17% | -$247K |
|
6674
PUT
Sasol
SSL
$7.71B
| $1.07M | ﹤0.01% |
157,700
+133,900
| +563% | +$993K |
|
6675
State Street SPDR S&P Pharmaceuticals ETF
XPH
$536M
| $1.07M | ﹤0.01% |
24,025
+23,936
| +26,894% | +$1.02M |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.